Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence

High-grade serous ovarian carcinoma (HGSOC) is a leading cause of mortality among women worldwide. Currently, there is no clear consensus over the regime these patients should receive. The main two options are upfront debulking surgery with adjuvant chemotherapy or neoadjuvant chemotherapy followed...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsonis, Orestis, Gkrozou, Fani, Vlachos, Konstantinos, Paschopoulos, Minas, Mitsis, Michail C., Zakynthinakis-Kyriakou, Nikolaos, Boussios, Stergios, Pappas-Gogos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Ovarian Cancer: State of the Art and Perspectives of Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812243/
https://www.ncbi.nlm.nih.gov/pubmed/33490219
http://dx.doi.org/10.21037/atm-20-1620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812243/
https://www.ncbi.nlm.nih.gov/pubmed/33490219
http://dx.doi.org/10.21037/atm-20-1620

Ejemplares similares